| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69238-2113-6 | 69238-2113 | HUMAN PRESCRIPTION DRUG | Risperidone | Risperidone | TABLET | ORAL | 20210801 | N/A | ANDA | ANDA078071 | Amneal Pharmaceuticals NY LLC | RISPERIDONE | 4 mg/1 | 60 TABLET in 1 BOTTLE (69238-2113-6) |
| 42291-909-50 | 42291-909 | HUMAN PRESCRIPTION DRUG | Risperidone | Risperidone | TABLET | ORAL | 20210910 | N/A | ANDA | ANDA078071 | AvKARE | RISPERIDONE | .5 mg/1 | 500 TABLET in 1 BOTTLE (42291-909-50) |
| 42291-911-60 | 42291-911 | HUMAN PRESCRIPTION DRUG | Risperidone | Risperidone | TABLET | ORAL | 20210922 | N/A | ANDA | ANDA078071 | AvKARE | RISPERIDONE | 2 mg/1 | 60 TABLET in 1 BOTTLE (42291-911-60) |
| 42291-913-60 | 42291-913 | HUMAN PRESCRIPTION DRUG | Risperidone | Risperidone | TABLET | ORAL | 20210922 | N/A | ANDA | ANDA078071 | AvKARE | RISPERIDONE | 4 mg/1 | 60 TABLET in 1 BOTTLE (42291-913-60) |